A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the clearest roadmaps to date for understanding and treating liver cancer, one of the ...

The investigators explained that GLP-1 receptor agonists appear to be able to help resolve MASH without worsening fibrosis. Those findings have been confirmed in mouse models and in multiple studies ...

On Thursday, OpenAI announced it had developed a large language model specifically trained on common biology workflows.

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...

UCLA researchers have identified a population of dysfunctional immune cells — dubbed “zombie macrophages” — that accumulates in the liver during aging and fatty liver disease, driving the chronic ...

A rogue set of “zombie” immune cells may be driving aging and fatty liver disease by flooding tissues with inflammation.

The publication, titled “ Comparative characterization of Cas12f orthologs reveals mechanistic features underlying enhanced genome editing efficiency” highlights the potential of MG119-28 (formally ...

It did not take long after the discovery of X-rays in the 1890s for scientists to begin exploring the harmful effects of ...

Primary liver cancer continues to pose a major global health challenge, ranking as the third leading cause of cancer-related deaths worldwide.

Scientists are rethinking how to treat a widespread genetic cholesterol disorder by targeting particle production instead of ...

PDS01ADC is a tumor-targeted IL-12 immunocytokine designed to activate the immune system directly within the tumor ...